Results 11 to 20 of about 40,951 (233)

DECOMPENSATED URINARY BLADDER DUE TO BENIGN PROSTATIC HYPERPLASIA (LITERATURE REVIEW)

Проблеми екології та медицини, 2022
We conducted an analytical review of the literature on the problem of bladder decompensation in patients with benign prostatic hyperplasia. Benign prostatic hyperplasia is one of the most common diseases in aging men. As is known, with the development of
O.O. Sherstyuk, Y.V. Sarychev, S.M. Suprunenko, S.A. Sukhomlin, G.L. Pustovoit   +4 more
doaj   +1 more source

Prostatic Hyperplasia [PDF]

The Journal of Urology, 1998
This study was designed to investigate whether GH and insulin-like growth factor I (IGF-I) excess could lead to the development of benign prostatic hyperplasia and/or prostatic carcinoma. Prostatic diameters and volume as well as the occurrence of prostatic diseases were studied by ultrasonography in 10 untreated acromegalic patients less than 40 yr of
COLAO, ANNAMARIA, P. Marzullo, D. Ferone, S. Spiezia, G. Cerbone, V. Marinò, DI SARNO, ANTONELLA, MEROLA, BARTOLOMEO, LOMBARDI, GAETANO   +8 more
openaire   +5 more sources

A case of giant prostatic hyperplasia

Asian Journal of Urology, 2016
Benign prostatic hyperplasia (BPH) is one of the most common conditions experienced by aging males and a frequent cause of bladder outlet obstruction and macroscopic haematuria.
Luke Wang, Paul Davis, Kevin McMillan
doaj   +1 more source

Juvenile prostatic hyperplasia

Urology, 2005
Benign prostatic hyperplasia is common in aging men, but rare in childhood. We report a case of juvenile prostatic hyperplasia in a 10-year-old boy, who visited our clinic for hematuria and voiding symptoms. Radiologic studies revealed a huge prostate protruding into the bladder. The prostate was 33 g.
Young Deuk, Choi, Nam Hoon, Cho, Duk Hyung, Kwon, Won Jae, Yang, Young Taik, Oh, Seung Kang, Choi   +5 more
openaire   +3 more sources

Antioxidant capacity of Chuquiraga spinosa Less and Senecio rhizomatus Rusby and their effects on the progression of testosterone enanthate-induced prostatic hyperplasia in rats [PDF]

Journal of Pharmacy & Pharmacognosy Research
Context: Benign prostatic hyperplasia affects men older than 50 years and can progress to atypical prostatic hyperplasia. Conventional pharmacotherapy causes adverse effects, affecting adherence and leading to the use of phytotherapy as a complementary ...
Hugo Jesús Justil-Guerrero, Jorge Luis Arroyo-Acevedo, Juan Pedro Rojas-Armas, Carlos Javier Justil-Guerrero, María Cecilia Rondón-Ramos, Jessica Yolanda Huarcaya-Rojas   +5 more
doaj   +1 more source

The Influencing Role of Diabetes Mellitus and Hypertension in the Establishment of Benign Prostatic Hyperplasia

Journal of Nobel Medical College, 2020
Background: Benign prostatic hyperplasia is regarded as non-malignant growth of prostatic tissueIt is the most common benign tumor in men, and the incidence is age related. In men aged more than 50 years, it is the fourth most prevalent disease.
Ram Sagar Shah, Rabindra Tamang
doaj   +1 more source

Studies on Chromatographic Fingerprint and Fingerprinting Profile-Efficacy Relationship of Saxifraga stolonifera Meerb.

Molecules, 2015
This work investigated the spectrum-effect relationships between high performance liquid chromatography (HPLC) fingerprints and the anti-benign prostatic hyperplasia activities of aqueous extracts from Saxifraga stolonifera.
Xing-Dong Wu, Hua-Guo Chen, Xin Zhou, Ya Huang, En-Ming Hu, Zheng-Meng Jiang, Chao Zhao, Xiao-Jian Gong, Qing-Fang Deng   +8 more
doaj   +1 more source

Immunohistochemical Expression of Nkx3.1 in Prostatic Adenocarcinoma and Benign Prostatic Hyperplasia at a Tertiary Care Hospital in Karachi

Journal of Gandhara Medical and Dental Sciences, 2023
OBJECTIVES To determine NKX3.1 expression in prostatic adenocarcinoma and benign prostate hyperplasia on Immunohistochemistry at a tertiary care hospital in Karachi.
Beenish Hussain, Syeda Naveera Raza, Amna Hussain, Ramsha Faridi, Saman Nadeem, Yusra Saleem   +5 more
doaj   +1 more source

Quantitation of α_1A and α_1D-adrenoceptor mRNA in prostate tissues from patients with symptomatic benign prostatic hyperplasia

Journal of Pathology of Nepal, 2011
Background: To treat symptomatic benign prostatic hyperplasia α1-adrenoceptor antagonists with little antagonism at α1b-adrenoceptor were used to avoid orthostatic hypotension.
B Acharya, H Okada, G Aryal, T Shirakawa, N Hinata, A Gotoh   +5 more
doaj   +1 more source

Role of gangliosides in prostate pathology [PDF]

Romanian Journal of Infectious Diseases, 2016
Molecular pathology of benign prostatic hyperplasia is multifactorial and involves endocrine, biochemical, immunological interactions. The mechanisms involved in the onset and progression of benign prostatic hyperplasia are: infections, 50 years of age ...
Ilinca Nicolae, Corina-Daniela Ene, Simona Roxana Georgescu   +2 more
doaj   +1 more source